Clms - OmicsDI

Show results for

Unknown (61)
Proteomics (36)
Genomics (4)

Organisms

Schizophyllum commune H4-8 (30)
Mycobacterium tuberculosis SP7 (30)
Salmonella enterica subsp. enterica serovar Typhimurium str. T000240 (30)
Oryza sativa Japonica Group (30)
Rabbit calicivirus (30)
Crotalus durissus terrificus (30)
Eriocheir sinensis (30)
Candidatus Endoriftia persephonae (30)
Mycobacterium tuberculosis SP10 (30)
Mycobacterium tuberculosis SP13 (30)
Cotesia typhae (30)
Mycobacterium tuberculosis SP22 (30)
Cepaea nemoralis (30)
Geobacillus kaustophilus HTA426 (30)
Enterobacter ludwigii (30)
Trichoderma asperellum CBS 433.97 (30)
Corynebacterium diphtheriae bv. mitis str. ISS 3319 (30)
Nakaseomyces glabratus (30)
Olea europaea (30)
Mumps virus strain Enders (30)
Chlamydomonas reinhardtii (30)
Deinococcus deserti VCD115 (30)
Lama (30)
Planorbella pilsbryi (30)
Paradendryphiella salina (30)
Homo sapiens (5)
Schizosaccharomyces pombe (1)
Tetrahymena (1)
Escherichia coli (1)
Saccharomyces cerevisiae (1)

Repository

pride (30)
EGA (4)
jPOST (4)
iProX (1)
MassIVE (1)

Tissue

Cell culture (4)
Blood serum (1)
Cell suspension culture (1)
Blood plasma (1)
Permanent cell line cell (1)

Disease

Severe acute respiratory syndrome (1)
Cervix carcinoma (1)

Technology Type

Mass Spectrometry (30)
Chemical cross-linking coupled with mass spectrometry proteomics (27)
Affinity purification coupled with mass spectrometry proteomics (3)
Shotgun proteomics (2)

Instrument Platform

LTQ Orbitrap Velos (1)
Q Exactive (1)

Publication Date

2020 (8)
2023 (6)
2022 (5)
2024 (4)
2021 (4)
2016 (2)
2018 (2)
2017 (2)
2015 (2)
2019 (1)

Release Date

2023 (11)
2022 (9)
2020 (8)
2024 (6)
2021 (6)
2025 (4)
2018 (4)
2016 (4)
2019 (3)
2017 (2)
2015 (1)
2013 (1)
2012 (1)
2009 (1)

Lab affiliation

1. Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada; 2. University of Victoria Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia, Canada; 3. Gerald Bronfman Department of Oncology, Jewish General Hospital, Montreal, Quebec, Canada; 4. Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada (2)
Analytics Core Facility Essen (ACE), Chemische Biologie, Universität Duisburg-Essen, ZMB, Germany (2)
Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK; Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany. (1)
University of Edinburgh; Technische Universität Berlin (1)
Technischen Universität Berlin wellcome trust centre for cell biology, University of Edinburgh (1)
University of Edinburgh; Technische Universit��t Berlin (1)
Wellcome Centre for Cell Biology, University of Edinburgh Institute of Biotechnology, Technische Universität Berlin (1)
Structural Motility, UMR 144 CNRS/Curie Institute, PSL Research University, 26 rue d’Ulm, 75258 Paris cedex 05, France (1)
Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany Wellcome Centre for Cell Biology, University of Edinburgh, Max Born Crescent, Edinburgh, EH9 3BF, UK (1)
Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany Wellcome Centre for Cell Biology, University of Edinburgh, Max Born Crescent, Edinburgh, EH9 3BF, UK (1)
Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh Department of Bioanalytics, Institute of Biotechnology, Technische Universität Berlin (1)
Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK (1)
Nir Kalisman, Dept. of Biological Chemistry, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel (1)
Biological chemistry department, Alexander Silberman Institute Of Life Sciences, Hebrew University (1)
Technische Universität Berlin, Chair of Bioanalytics, 10623 Berlin, Germany (1)
Institut de Génétique et de Biologie Moléculaire et Cellulaire IGBMC, Illkirch, France  Centre National de la Recherche Scientifique, UMR7104, Illkirch, France  Institut National de la Santé et de la Recherche Médicale, U964, Illkirch, France  Université de Strasbourg, Illkirch, France (1)
Dept. of Biological Chemistry, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel (1)
1. Department of Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany, 2. Wellcome Trust Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3JR, United Kingdom (1)
Department of Cell Biology, Harvard Medical School Department of Cancer Biology, Dana-Farber Cancer Institute (1)
1. Department of Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany, 2. Wellcome Trust Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3JR, United Kingdom; (1)
Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany Wellcome Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, Scotland, United Kingdom (1)
Technische Universität Berlin The University of Edinburgh (1)
Institute for Systems Biology (1)
Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, School of Biological Sciences, University of Edinburgh, UK Department of Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, Germany (1)
Technische Universität Berlin, Chair of Bioanalytics, 10623 Berlin, Germany Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK Si-M/"Der Simulierte Mensch", a Science Framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany (1)
University of Edinburgh (1)
Biomedicine Discovery Institute, Monash University, Clayton 3800, Victoria, Australia (1)
The Institute of Cancer Research (1)

Previous page
1 / 11
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 11
Next page

Sort by:

Relevance

Page size

Identification of novel interferon responsive protein partners of human leukocyte antigen A (HLA-A) using cross-linking mass spectrometry (CLMS) approach.

Not available

S-EPMC9653400 | biostudies-literature

Crosslinking/mass spectrometry (CLMS) analysis of Tetrahymena ODA-Q22MS1 complex

The outer dynein arms (ODAs) are the main force generators in cilia. Crosslinking/mass spectrometry (CLMS) was applied to investigate the interaction between ODA and its binding factor Q22MS1.

ORGANISM(S): Tetrahymena

2021-12-07 | PXD022936 | JPOST Repository

Controlled comparison of species- and community-level models across novel climates and communities.

Not available

S-EPMC4810853 | biostudies-literature

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases.

Not available

S-EPMC6118248 | biostudies-literature

Structural analysis of neurofibromin by crosslinking mass spectrometry

Neurofibromin (NF1) is a fundamental inhibitor of cell growth that is conserved from yeast to humans. NF1 negatively regulates oncogenic RAS proteins by accelerating the hydrolysis of RAS-bound GTP. This activity blocks growth factor signalling upstream of both mitogen-activated protein kinase (MAPK...

ORGANISM(S): Homo sapiens (Human)

2022-08-12 | PXD023593 | Pride

Quantitative cross-linking/mass spectrometry

Dynamic proteins and multi-protein complexes govern most biological processes. Cross-linking/mass spectrometry (CLMS) is increasingly successful in providing residue- resolution data on static proteinaceous structures. Here we investigate the technical feasibility of recording dynamic processes usin...

ORGANISM(S): Homo sapiens (Human)

2015-06-08 | PXD002142 | Pride

Protein dynamics Structual biology Quantitation Cross-linking

Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels.

Not available

S-EPMC4673155 | biostudies-literature

Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.

Not available

S-EPMC11758588 | biostudies-literature

Real-Time Split-Dose PET/CT-Guided Ablation Improves Colorectal Liver Metastasis Detection and Ablation Zone Margin Assessments without the Need for Repeated Contrast Injection.

Not available

S-EPMC9777508 | biostudies-literature